Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

APPLE Score

APPLE Score: Predicts the risk of atrial fibrillation recurrence after a primary catheter ablation procedure.

Age > 65 years
Persistent AF (not paroxysmal)
Impaired eGFR (< 60 mL/min/1.73m2)
Left Atrial diameter ≥ 43 mm
Ejection Fraction (LVEF) < 50%
Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Patients with atrial fibrillation being evaluated for catheter ablation (Pulmonary Vein Isolation - PVI)
To predict the probability of long-term rhythm success and set realistic patient expectations prior to the procedure

How it Works

The APPLE Variables

01
A - Age > 65 years (1 point)
02
P - Persistent AF (1 point): As opposed to paroxysmal AF. Suggests greater atrial remodeling.
03
P - Impaired eGFR (1 point): < 60 mL/min/1.73m2, a marker of systemic inflammation and fibrosis.
04
L - LA diameter ≥ 43 mm (1 point): Structural stretching makes maintaining sinus rhythm difficult.
05
E - Ejection Fraction < 50% (1 point): Heart failure promotes atrial stretch and neurohormonal activation.

Clinical Pearls

Modifying the Ablation Strategy

While standard PVI is highly effective for paroxysmal AF in normal hearts (Score 0-1), patients with higher APPLE scores (≥3) often require more extensive ablation techniques (e.g., posterior wall isolation, complex fractionated atrial electrogram ablation) or continuation of antiarrhythmic drugs post-procedure to maintain sinus rhythm.

Risk Factor Modification

The APPLE score highlights modifiable targets. E.g., improving eGFR through better HF/HTN management, or reverse remodeling the LA with ACE-inhibitors before attempting ablation.

The Evidence

Original Derivation

The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation.

Kornej J et al. • Clin Res Cardiol.. 2015;104(10):871-6. Derived from the Leipzig Heart Center AF Ablation Registry in patients undergoing primary ablation.

Next Steps

Complementary Calculators

EHRA Score
CHA2DS2-VASc Score
HAS-BLED Score
Bazett’s Formula (QTc)

Last Comprehensive Review: 2026-07-17

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Patients with atrial fibrillation being evaluated for catheter ablation (Pulmonary Vein Isolation - PVI)
To predict the probability of long-term rhythm success and set realistic patient expectations prior to the procedure

How it Works

The APPLE Variables

01
A - Age > 65 years (1 point)
02
P - Persistent AF (1 point): As opposed to paroxysmal AF. Suggests greater atrial remodeling.
03
P - Impaired eGFR (1 point): < 60 mL/min/1.73m2, a marker of systemic inflammation and fibrosis.
04
L - LA diameter ≥ 43 mm (1 point): Structural stretching makes maintaining sinus rhythm difficult.
05
E - Ejection Fraction < 50% (1 point): Heart failure promotes atrial stretch and neurohormonal activation.

Clinical Pearls

Modifying the Ablation Strategy

While standard PVI is highly effective for paroxysmal AF in normal hearts (Score 0-1), patients with higher APPLE scores (≥3) often require more extensive ablation techniques (e.g., posterior wall isolation, complex fractionated atrial electrogram ablation) or continuation of antiarrhythmic drugs post-procedure to maintain sinus rhythm.

Risk Factor Modification

The APPLE score highlights modifiable targets. E.g., improving eGFR through better HF/HTN management, or reverse remodeling the LA with ACE-inhibitors before attempting ablation.

The Evidence

Original Derivation

The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation.

Kornej J et al. • Clin Res Cardiol.. 2015;104(10):871-6. Derived from the Leipzig Heart Center AF Ablation Registry in patients undergoing primary ablation.

Next Steps

Complementary Calculators

EHRA Score
CHA2DS2-VASc Score
HAS-BLED Score
Bazett’s Formula (QTc)

Last Comprehensive Review: 2026-07-17

Recent Journal Updates

Cancer MedicineJul 23, 2026
High SIGLEC10‐Expressing Tumor‐Associated Macrophages Participate in Remodeling the Tumor Immune Microenvironment and Predict Poor Prognosis in Colorectal Cancer

Clinical Context

We think this has broad domain relevance to APPLE Score.

JAMAJul 21, 2026
Errors in Figures

Clinical Context

We think this has broad domain relevance to APPLE Score.

British J Clinical PharmacologyJul 21, 2026
Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study

Clinical Context

We think this has broad domain relevance to APPLE Score.